FDA's Hasty Policymaking Approach Faces APA Challenges

The U.S. Department of Health and Human Services and, in turn, the U.S. Food and Drug Administration, have been working to implement President Donald Trump's deregulatory initiatives at breakneck speed....

Already a subscriber? Click here to view full article